Stars and Stripes stripes.com 30 Dec, 2020 08:45 am

UK approves use of second COVID-19 vaccine with easier storage

UK approves use of second COVID-19 vaccine with easier storage
Britain authorized emergency use of the vaccine developed by Oxford University and U.K.-based drugmaker AstraZeneca, which is expected to be adopted by many countries because of its low cost and ease of use.

UK approves use of second COVID-19 vaccine with easier storage This undated file photo issued by the University of Oxford, shows of vial of coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England.” The Department of Health said it had accepted a recommendation from the Medicines and Healthcare Products Regulatory Agency to authorize the vaccine developed by Oxford University and U.Britain has bought 100 million doses of the vaccine, and plans to begin injections within days.The initiative, led by WHO and the vaccines alliance GAVI, has secured access to at least 100 million doses of the vaccine, with options and other deals to buy more.

In June, the pharmaceutical company announced that the Serum Institute would produce 400 million doses by the end of 2020 but as of early December, only about 50 million doses had been manufactured after production was halted several times.The vaccine will now become the second COVID-19 vaccine in use in Britain.

Read full story at stripes.com